Thirumalai Chemicals Completes ₹56.14 Crore Preferential Share Allotment

1 min read     Updated on 28 Nov 2025, 10:14 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Thirumalai Chemicals has successfully completed its preferential share allotment, raising ₹56.14 crore through the issuance of 18,96,614 equity shares at ₹296 per share to promoter group entities. The Fund Raising Committee approved the allotment on December 23, 2025, following overwhelming shareholder support with 99.99% votes in favor through postal ballot.

25893872

*this image is generated using AI for illustrative purposes only.

Thirumalai Chemicals Limited has successfully completed its preferential share issue, allotting 18,96,614 equity shares at ₹296 per share to promoter group entities. The Fund Raising Committee of the Board approved the allotment on December 23, 2025, raising a total of ₹56.14 crore as previously planned.

Share Allotment Details

The company has completed the allotment process following overwhelming shareholder approval received earlier through postal ballot. The allotment details are summarized below:

Parameter: Details
Total Shares Allotted: 18,96,614 equity shares
Issue Price: ₹296 per share (including premium of ₹295)
Face Value: ₹1 per share
Total Amount Raised: ₹56,13,97,744
Stock Exchange Approval: Received on December 16, 2025

Shareholder Approval Background

The preferential share issue had received exceptional shareholder support through postal ballot:

Voting Details: Results
Votes in Favor: 4,45,95,980 (99.99% of valid votes)
Total Valid Votes: 4,45,99,144
Resolution Type: Special Resolution

Major Allottees

The shares have been allocated among various promoter group entities, with the largest allocations going to:

Allottee: Shares Allotted Amount (₹)
Ultramarine and Pigments Ltd: 15,20,270 4,49,99,920.00
Parthasarathy Rangaswamy jointly with Bhooma Parthasarathy: 1,21,621 3,59,99,816.00
Bhooma Parthasarathy jointly with Parthasarathy Rangaswamy: 64,189 1,89,99,944.00

Impact on Share Capital

The allotment has resulted in an increase in the company's issued, subscribed, and paid-up share capital. The newly allotted equity shares rank pari-passu in all respects with the existing equity shares of the company.

Financial Position Context

This capital raise comes at a time when TCL's balance sheet shows robust growth:

Financial Metric: Current Year Previous Year Growth
Total Assets: ₹2,141.40 crore ₹1,732.60 crore +23.59%
Investments: ₹1,150.90 crore ₹656.60 crore +75.28%
Shareholders' Capital: ₹1,106.70 crore ₹984.00 crore +12.47%

The successful completion of this preferential issue strengthens the company's capital base and demonstrates strong promoter confidence in the company's growth prospects. The additional funds are expected to support the company's strategic initiatives and expansion plans.

Historical Stock Returns for Thirumalai Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.33%-6.06%-1.56%-23.95%-32.99%+125.89%
Thirumalai Chemicals
View in Depthredirect
like16
dislike

Thirumalai Chemicals Utilizes Rs 311.11 Crore from Preferential Issue, Reports No Deviation

2 min read     Updated on 15 Nov 2025, 07:58 AM
scanx
Reviewed by
Riya DScanX News Team
Overview

Thirumalai Chemicals has utilized Rs 311.11 crore out of Rs 450.63 crore raised from a preferential issue. Rs 211.94 crore was allocated for capital expenditure in US subsidiary TCL Specialties LLC, and Rs 99.17 crore for operational payments. The remaining Rs 139.52 crore is held in various bank accounts. CRISIL Ratings confirmed no deviations from stated objectives. The company aims to complete investment in TCL Specialties LLC by December 2025, with a slight delay in general corporate purpose fund utilization. Separately, the company faces a Rs 47.53 crore tax demand for excess Input Tax Credit, which it plans to contest.

24719339

*this image is generated using AI for illustrative purposes only.

Thirumalai Chemicals Limited has reported significant progress in utilizing funds from its recent preferential issue, according to the latest Monitoring Agency Report for the quarter ended September 30, 2025. The company has deployed Rs 311.11 crore out of the total Rs 450.63 crore raised, with no deviations from the stated objectives.

Capital Expenditure and Operational Payments

The company has allocated Rs 211.94 crore towards capital expenditure for its US subsidiary, TCL Specialties LLC. This investment aligns with Thirumalai Chemicals' strategy to expand its presence in the United States market.

Additionally, Rs 99.17 crore has been utilized for operational payments, including:

Purpose Amount (Rs in crore)
Raw material purchase from Reliance Industries Ltd. 83.00
Raw material purchase from Total Energies Trading Asia Pte Ltd. 15.00
Sales Invoice Discounting facility repayment 1.17

Fund Utilization and Monitoring

CRISIL Ratings, acting as the Monitoring Agency, has confirmed that there are no deviations from the stated objectives of the preferential issue. The remaining Rs 139.52 crore is currently held across various bank accounts of the company and its subsidiaries:

Entity Bank Amount (Rs in crore)
Thirumalai Chemicals Ltd. IDFC First Bank (Current Account) 10.83
Thirumalai Chemicals Ltd. IDFC First Bank (Monitoring Account) 13.10
TCL Global B.V. (Subsidiary) HSBC Bank 107.93
TCL Specialties LLC (Step-down Subsidiary) The Huntington National Bank 7.66

Project Timeline and Utilization

The company aims to complete the investment in TCL Specialties LLC by December 2025, as originally planned. However, there is a slight delay in utilizing funds for general corporate purposes, which was initially scheduled for October 2025 but is now expected to be completed by November 2025.

Additional Developments

In a separate disclosure, Thirumalai Chemicals has received an intimation of tax ascertained as being payable under Section 73 of the CGST Act, 2017. The Assistant Commissioner (ST), Ranipet, Tamil Nadu, has raised a demand of Rs 47.53 crore for excess Input Tax Credit (ITC) availed based on GSTR 9 scrutiny.

The company believes that the tax demand is erroneous and not sustainable. Thirumalai Chemicals plans to pursue legal remedies and expects any potential financial implications to be insignificant, with no material impact on its financial position.

This report demonstrates Thirumalai Chemicals' commitment to transparent fund utilization and strategic expansion, while also highlighting its proactive approach to addressing regulatory challenges.

Historical Stock Returns for Thirumalai Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.33%-6.06%-1.56%-23.95%-32.99%+125.89%
Thirumalai Chemicals
View in Depthredirect
like16
dislike
More News on Thirumalai Chemicals
Explore Other Articles
Power Mech Projects Subsidiary Secures ₹1,563 Crore BESS Contract from WBSEDCL 1 hour ago
Elpro International Acquires Additional Stake in Sundrop Brands for ₹39.18 Crores 1 hour ago
Transformers & Rectifiers Targets ₹8000 Crore Order Book by FY26 End 3 hours ago
Reliance Industries Schedules Board Meeting for January 16, 2026 to Approve Q3FY26 Financial Results 4 hours ago
Krishival Foods Limited Completes Rights Issue Allotment of 3.33 Lakh Partly Paid-Up Equity Shares 3 hours ago
Raymond Realty Board Approves Employee Stock Option Plan 2025 Following Demerger 3 hours ago
221.71
-0.73
(-0.33%)